Product Description
2 MG Bortezomib Injection IP is a liquid drug type injection that is used for the treatment of multiple myeloma and mantle cell lymphoma. Bortezomib is a proteasome inhibitor that blocks the action of enzymes that break down proteins, leading to the accumulation of proteins within the cancer cells and their subsequent death. This injection is stored in a dry place and comes in a physical form of liquid. It is manufactured in India and is available for export, supply, and trade.
FAQs of 2 MG Bortezomib Injection IP:
Q: What is the dosage form of 2 MG Bortezomib Injection IP?
A: 2 MG Bortezomib Injection IP is a liquid drug type injection.
Q: What is the storage instruction for 2 MG Bortezomib Injection IP?
A: 2 MG Bortezomib Injection IP should be stored in a dry place.
Q: What is the physical form of 2 MG Bortezomib Injection IP?
A: 2 MG Bortezomib Injection IP comes in a physical form of liquid.
Q: Where is 2 MG Bortezomib Injection IP manufactured?
A: 2 MG Bortezomib Injection IP is manufactured in India.
Q: What is the business type for 2 MG Bortezomib Injection IP?
A: 2 MG Bortezomib Injection IP is available for export, supply, and trade.